# NicVAX/Placebo as an Aid for Smoking Cessation

> **NCT00836199** · PHASE3 · COMPLETED · sponsor: **Nabi Biopharmaceuticals** · enrollment: 1000 (actual)

## Conditions studied

- Smoking Cessation
- Smoking
- Tobacco Cessation

## Interventions

- **BIOLOGICAL:** NicVAX vaccine
- **BIOLOGICAL:** Placebo vaccine

## Key facts

- **NCT ID:** NCT00836199
- **Lead sponsor:** Nabi Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2012-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836199, "NicVAX/Placebo as an Aid for Smoking Cessation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00836199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*